17-29475668-A-G
Variant summary
Our verdict is Likely pathogenic. Variant got 6 ACMG points: 6P and 0B. PVS1_ModeratePM2PP5_Moderate
The ENST00000261716.8(TAOK1):c.205-2A>G variant causes a splice acceptor change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Likely pathogenic (★).
Frequency
Consequence
ENST00000261716.8 splice_acceptor
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TAOK1 | NM_020791.4 | c.205-2A>G | splice_acceptor_variant | ENST00000261716.8 | NP_065842.1 | |||
TAOK1 | NM_025142.1 | c.205-2A>G | splice_acceptor_variant | NP_079418.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TAOK1 | ENST00000261716.8 | c.205-2A>G | splice_acceptor_variant | 1 | NM_020791.4 | ENSP00000261716 | P1 | |||
TAOK1 | ENST00000536202.1 | c.205-2A>G | splice_acceptor_variant | 1 | ENSP00000438819 | |||||
TAOK1 | ENST00000583121.5 | c.205-2A>G | splice_acceptor_variant | 3 | ENSP00000464562 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 28
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Developmental delay with or without intellectual impairment or behavioral abnormalities Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | MVZ Medizinische Genetik Mainz | Feb 19, 2024 | ACMG Criteria: PVS1_STR,PM1_SUP,PP2 - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.